Literature DB >> 16205473

Bioimpedance, dry weight and blood pressure control: new methods and consequences.

Martin K Kuhlmann1, Fansan Zhu, E Seibert, Nathan W Levin.   

Abstract

PURPOSE OF REVIEW: Chronic overhydration contributes to the development of left ventricular hypertrophy and a high cardiovascular mortality in end-stage renal disease. Assessment of dry weight is highly dependent on clinical assessment. Bioimpedance technology offers the potential to quantify body fluid compartments and to facilitate dry weight prescription. This review covers recent innovative approaches to dry weight assessment using bioimpedance technology. RECENT
FINDINGS: Three different bioimpedance approaches to determine dry weight have been published. The normovolemic/hypervolemic slope method applies whole body multifrequency bioimpedance to assess predialysis total body extracellular fluid volume and compares the extracellular fluid volume/body weight relation at hypervolemia with the standard value in normovolemic individuals. The resistance-reactance graph method uses whole body single frequency bioimpedance for assessment of hydration state and nutritional status from height-adjusted resistance and reactance. The resulting resistance-reactance vector is set in relation to a distribution range in a normovolemic population. An alternative method uses segmental bioimpedance in the form of continuous intradialytic calf bioimpedance to record changes in calf extracellular volume during dialysis. Dry weight by this method is defined as the weight at which calf extracellular volume is not further reduced despite ongoing ultrafiltration.
SUMMARY: Although promising, none of these methods has gained much popularity, probably due to the difficulties in understanding bioimpedance and the lack of gold standard methods for dry weight determination. Bioimpedance will improve dry weight assessment, but further refinement of the methods as well as large-scale clinical studies to demonstrate the accuracy and the clinical value of objective dry weight determination are needed.

Entities:  

Mesh:

Year:  2005        PMID: 16205473     DOI: 10.1097/01.mnh.0000185983.48319.00

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  19 in total

1.  Changes in arterial stiffness following dialysis in relation to overhydration and to endothelial function.

Authors:  Simona Hogas; Serban Ardeleanu; Liviu Segall; Dragomir Nicolae Serban; Ionela Lacramioara Serban; Mihai Hogas; Mugurel Apetrii; Mihai Onofriescu; Radu Sascau; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-03-19       Impact factor: 2.370

2.  Hypervolemia is associated with increased mortality among hemodialysis patients.

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2010-07-12       Impact factor: 10.190

3.  Determinants and short-term reproducibility of relative plasma volume slopes during hemodialysis.

Authors:  Sanjiv Anand; Arjun D Sinha; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 8.237

4.  The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies.

Authors:  Luminita Voroneanu; Claudiu Cusai; Simona Hogas; Serban Ardeleanu; Mihai Onofriescu; Ionut Nistor; Octavian Prisada; Radu Sascau; David Goldsmith; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2010-06-04       Impact factor: 2.370

5.  Impedance ratio: a novel marker and a powerful predictor of mortality in hemodialysis patients.

Authors:  C Demirci; G Aşcı; M S Demirci; M Özkahya; H Töz; S Duman; S Sipahi; S Erten; M Tanrısev; E Ok
Journal:  Int Urol Nephrol       Date:  2016-04-19       Impact factor: 2.370

6.  Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes.

Authors:  Chen Huan-Sheng; Chang Yeong-Chang; Hsieh Ming-Hsing; Tseng Fan-Lieh; Lin Chu-Cheng; Wu Tsai-Kun; Chen Hung-Ping; Hung Sze-Hung; Chiu Hsien-Chang; Lee Chia-Chen; Hou Chun-Cheng; Cheng Chun-Ting; Liou Hung-Hsiang; Lin Chun-Ju; Lim Paik-Seong
Journal:  Int Urol Nephrol       Date:  2016-09-12       Impact factor: 2.370

7.  Comparison of multiple fluid status assessment methods in patients on chronic hemodialysis.

Authors:  Giannis Alexiadis; Stelios Panagoutsos; Stefanos Roumeliotis; Ilias Stibiris; Angelos Markos; Konstantia Kantartzi; Ploumis Passadakis
Journal:  Int Urol Nephrol       Date:  2016-12-10       Impact factor: 2.370

8.  B-type natriuretic peptide is not a volume marker among patients on hemodialysis.

Authors:  Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2013-03-22       Impact factor: 5.992

9.  Whole-body single-frequency bioimpedance analysis in pediatric hemodialysis patients.

Authors:  Gia Oh; Cynthia Wong; Brandy Begin; Kari Salsbery; Scott Sutherland; Abanti Chaudhuri
Journal:  Pediatr Nephrol       Date:  2014-02-26       Impact factor: 3.714

10.  Disordered aldosterone-volume relationship in end-stage kidney disease.

Authors:  Andrew S Bomback; Abhijit V Kshirsagar; Maria E Ferris; Philip J Klemmer
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2009-10-28       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.